Global Information
회사소개 | 문의

세계의 이식 진단 시장 예측(-2023년) : 기술별(PCR, NGS, 생거 시퀀싱), 제품별(기구, 시약, 소프트웨어), 용도별(HLA, 혈액 프로파일, 병원균 검출), 타입별(심장, 신장, 간, 줄기세포), 최종사용자별

Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User - Global Forecast to 2023

리서치사 MarketsandMarkets
발행일 2018년 06월 상품 코드 421119
페이지 정보 영문 222 Pages
가격
US $ 5,650 ₩ 6,446,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,586,900 PDF by E-mail (5-user license) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,298,300 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,409,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 이식 진단 시장 예측(-2023년) : 기술별(PCR, NGS, 생거 시퀀싱), 제품별(기구, 시약, 소프트웨어), 용도별(HLA, 혈액 프로파일, 병원균 검출), 타입별(심장, 신장, 간, 줄기세포), 최종사용자별 Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User - Global Forecast to 2023
발행일: 2018년 06월 페이지 정보 : 영문 222 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계의 이식 진단 시장 규모는 2018년 34억 4,000만 달러에서 2023년까지 49억 1,000만 달러에 달할 것으로 예측되며, 2018-2023년간 연평균 복합 성장률(CAGR)은 7.4%를 나타낼 전망입니다. 이식 수술 증가, 이식 진단 분야의 기술 발전, 대상 연구활동에 대한 관민 자금 증가, 감염증 부담 증대가 시장 성장을 촉진하고 있습니다. 그러나, 차세대 시퀀싱(NGS)·PCR 진단 어세이의 고액 비용, 대상 수술에 대한 의료비 상환 가용성이 제한되고 있는 점은 예측기간 중 이식 진단 도입을 억제할 전망입니다.

세계의 이식 진단(Transplant Diagnostics) 시장에 대해 조사했으며, 용도·최종사용자·제품 및 서비스·이식 유형·지역별 시장 분석과 예측, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

  • 이식 진단 시장 개요
  • 이식 진단 시장 : 기술별
  • 이식 진단 시장 지역별 분석 : 용도별
  • 아시아태평양의 이식 진단 기술 시장 : 최종사용자별
  • 이식 진단 시장 지역별 분석 : 제품 및 서비스별
  • 이식 진단 시장 지역별 분석 : 이식 유형별
  • 이식 진단 시장 : 국가별

제5장 시장 개요

  • 서론
  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 주요 시장 기회
    • 주요 시장이 해결해야 할 과제

제6장 이식 진단 시장 지역별 분석 : 제품 및 서비스별

  • 서론
  • 시약 및 소모품
  • 장비
  • 소프트웨어 및 서비스

제7장 이식 진단 시장 : 기술별

  • 서론
  • 분자 어세이 기술
    • PCR 기반 분자 어세이 기술
      • 실시간 PCR
      • SSP-PCR(Sequence-specific primer-PCR)
      • SSO-PCR(Sequence-specific oligonucleotide-PCR)
      • 기타 PCR 기술
    • 시퀀싱형 분자 어세이 기술
      • 생거 시퀀싱
      • 차세대 시퀀싱(NGS)
      • 기타 시퀀싱 기술
  • 비분자 어세이 기술

제8장 이식 진단 시장 : 이식 유형별

  • 서론
  • 실질 장기 이식
  • 줄기세포 이식
  • 연조직 이식

제9장 이식 진단 시장 : 용도별

  • 서론
  • 진단 용도
    • 이식 전 진단
      • 감염증 진단
      • 조직적합성 진단
      • 혈액 프로파일링
    • 이식 후 진단
  • 연구 용도

제10장 이식 진단 시장 : 최종사용자별

  • 서론
  • 독립계 참조 실험실
  • 병원 및 이식센터
  • 연구소 및 대학기관

제11장 이식 진단 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 기타(RoW)

제12장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 경쟁 구도

제13장 기업 개요

  • 서론
  • TBECTON, DICKINSON AND COMPANY
  • BIOFORTUNA
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES
  • CAREDX
  • F. HOFFMAN-LA ROCHE LIMITED
  • GENDX
  • HOLOGIC
  • ILLUMINA
  • IMMUCOR
  • LUMINEX
  • MERCK KGAA
  • OMIXON
  • QIAGEN
  • THERMO FISHER SCIENTIFIC

제14장 부록

LSH 18.07.12

영문목차

"The transplant diagnostics market projected to grow at a CAGR of 7.4%."

The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal adoption of transplant diagnostics during the forecast period.

"The molecular assay technologies segment is poised to be the fastest-growing during the forecast period."

On the basis of technology, the transplant diagnostics market is segmented into molecular (PCR based assay and sequencing based assay technologies) and non-molecular assays. The molecular assay technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the technological benefits of molecular assays such as low turnaround time, high procedural efficacy, study of multiple samples, and real-time sample analysis.

"Asia Pacific is expected to register the highest growth rate during the forecast period."

Geographically, the transplant diagnostics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC transplant diagnostics market can be attributed to the increasing adoption of cutting-edge diagnostic technologies among medical professionals, rapid rise in geriatric population (especially in Japan and China), and universal government healthcare coverage in Japan (including for transplantation & related diagnostic procedures).

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type - Tier 1 - 25%, Tier 2 - 30% and Tier 3 - 45%
  • By Designation - C-level - 26%, Director-level - 30%, Others - 44%
  • By Region - North America - 34%, Europe - 26%, APAC - 23%, RoW - 17%

The global transplant diagnostics market is competitive, with a large number of global and local players. In 2017, the market was dominated by Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US). Product launches, market expansions, strategic acquisitions, and partnerships, agreements, & collaborations were the major strategies adopted by market players to achieve growth in the market.

Research Coverage:

This report studies the transplant diagnostics market based on technology, product, transplant type, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis-industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the transplant diagnostics market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the major players in the transplant diagnostics market. The report analyzes the transplant diagnostics market based on technology, product, transplant type, application, end user, and region
  • Product Development: Detailed insights on the research and development activities and product launches in the transplant diagnostics market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transplant diagnostics across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the transplant diagnostics market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transplant diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY USED FOR THE STUDY
  • 1.5. MAJOR MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2. PROCEDURE BASED MARKET ESTIMATION
    • 2.2.3. PRIMARY RESEARCH VALIDATION
  • 2.3. DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS
  • 2.5. RESEARCH LIMITATIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. TRANSPLANT DIAGNOSTICS MARKET OVERVIEW
  • 4.2. TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY
  • 4.3. REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION
  • 4.4. ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2018
  • 4.5. REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
  • 4.6. REGIONAL ANALYSIS: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE
  • 4.7. TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. KEY MARKET DRIVERS
      • 5.2.1.1. Increasing number of transplant procedures
      • 5.2.1.2. Technological advancements in the field of transplant diagnostics
      • 5.2.1.3. Increasing public-private funding for target research activities
      • 5.2.1.4. Growing burden of infectious diseases
    • 5.2.2. KEY MARKET RESTRAINTS
      • 5.2.2.1. High procedural cost of NGS and PCR-based diagnostic assays
      • 5.2.2.2. Limited reimbursements for target procedures
    • 5.2.3. KEY MARKET OPPORTUNITIES
      • 5.2.3.1. Rising adoption of cross-matching and chimerism testing during pre- & post-transplantation
      • 5.2.3.2. Increasing public awareness about organ donation and transplantation across emerging countries
    • 5.2.4. KEY MARKET CHALLENGES
      • 5.2.4.1. Significant gap between the number of organ donors and organs required annually
      • 5.2.4.2. Procedural and technical limitations associated with donor-recipient screening

6. TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES

  • 6.1. INTRODUCTION
  • 6.2. REAGENTS AND CONSUMABLES
  • 6.3. INSTRUMENTS
  • 6.4. SOFTWARE AND SERVICES

7. TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. MOLECULAR ASSAYS
    • 7.2.1. PCR-BASED MOLECULAR ASSAYS
      • 7.2.1.1. REAL-TIME PCR
      • 7.2.1.2. Sequence-specific primer-PCR
      • 7.2.1.3. Sequence-specific oligonucleotide-PCR
      • 7.2.1.4. Other PCR-based molecular assays
    • 7.2.2. SEQUENCING-BASED MOLECULAR ASSAYS
      • 7.2.2.1. Sanger sequencing
      • 7.2.2.2. Next-generation sequencing
      • 7.2.2.3. Other sequencing molecular assays
  • 7.3. NON-MOLECULAR ASSAYS

8. TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE

  • 8.1. INTRODUCTION
  • 8.2. SOLID ORGAN TRANSPLANTATION
    • 8.2.1. KIDNEY TRANSPLANTATION
    • 8.2.2. LIVER TRANSPLANTATION
    • 8.2.3. HEART TRANSPLANTATION
    • 8.2.4. LUNG TRANSPLANTATION
    • 8.2.5. PANCREAS TRANSPLANTATION
    • 8.2.6. OTHER ORGAN TRANSPLANTATIONS
  • 8.3. STEM CELL TRANSPLANTATION
  • 8.4. SOFT TISSUE TRANSPLANTATION

9. TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. DIAGNOSTIC APPLICATIONS
    • 9.2.1. PRE-TRANSPLANTATION DIAGNOSTICS
      • 9.2.1.1. Infectious disease testing
      • 9.2.1.2. Histocompatibility testing
      • 9.2.1.3. Blood profiling
    • 9.2.2. POST-TRANSPLANTATION DIAGNOSTICS
  • 9.3. RESEARCH APPLICATIONS

10. TRANSPLANT DIAGNOSTICS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. INDEPENDENT REFERENCE LABORATORIES
  • 10.3. HOSPITALS & TRANSPLANT CENTERS
  • 10.4. RESEARCH LABORATORIES & ACADEMIC INSTITUTES

11. TRANSPLANT DIAGNOSTICS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. UK
    • 11.3.3. FRANCE
    • 11.3.4. REST OF EUROPE
  • 11.4. ASIA PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA PACIFIC
  • 11.5. REST OF THE WORLD

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SCENARIO
    • 12.3.1. KEY PRODUCT LAUNCHES AND ENHANCEMENTS (2014 TO 2018)
    • 12.3.2. KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014 TO 2018)
    • 12.3.3. MAJOR ACQUISITIONS (2014 TO 2018)
    • 12.3.4. KEY EXPANSIONS (2014 TO 2018)

13. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 13.1. INTRODUCTION
  • 13.2. BECTON, DICKINSON AND COMPANY
  • 13.3. BIOFORTUNA
  • 13.4. BIOMERIEUX SA
  • 13.5. BIO-RAD LABORATORIES
  • 13.6. CAREDX
  • 13.7. F. HOFFMAN-LA ROCHE LIMITED
  • 13.8. GENDX
  • 13.9. HOLOGIC
  • 13.10. ILLUMINA
  • 13.11. IMMUCOR
  • 13.12. LUMINEX
  • 13.13. MERCK KGAA
  • 13.14. OMIXON
  • 13.15. QIAGEN
  • 13.16. THERMO FISHER SCIENTIFIC

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORTS
  • 14.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PUBLIC-PRIVATE INVESTMENTS AND RESEARCH GRANTS FOR THE DEVELOPMENT OF TRANSPLANT DIAGNOSTIC PRODUCTS, 2015-2018
  • TABLE 2: COST OF ASSAYS FOR MAJOR NGS/PCR-BASED GENOMIC TESTS IN EUROPE (AS OF 2014)
  • TABLE 3: MEDICAL REIMBURSEMENTS FOR TRANSPLANTATION PROCEDURES IN THE US (2017)
  • TABLE 4: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT & SERVICES, 2016-2023 (USD MILLION)
  • TABLE 5: TRANSPLANT DIAGNOSTICS MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 6: TRANSPLANT DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: TRANSPLANT DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 9: TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 10: TRANSPLANT DIAGNOSTICS MARKET FOR MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 12: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 13: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 14: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 15: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 16: TRANSPLANT DIAGNOSTICS MARKET FOR REAL-TIME PCR, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCE-SPECIFIC PRIMER-PCR, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: TRANSPLANT DIAGNOSTICS MARKET FOR OTHER PCR-BASED MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 21: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 22: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 23: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 24: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: TRANSPLANT DIAGNOSTICS MARKET FOR SANGER SEQUENCING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: TRANSPLANT DIAGNOSTICS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 27: TRANSPLANT DIAGNOSTICS MARKET FOR OTHER SEQUENCING MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 29: TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 30: TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 31: TRANSPLANT DIAGNOSTICS MARKET FOR NON-MOLECULAR ASSAYS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 32: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
  • TABLE 33: SOLID ORGAN TRANSPLANTATION MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 34: SOLID ORGAN TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: KIDNEY TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 36: LIVER TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 37: HEART TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 38: LUNG TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 39: PANCREAS TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 40: OTHER ORGAN TRANSPLANTATIONS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 41: STEM CELL TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 42: SOFT TISSUE TRANSPLANTATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 43: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 44: TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 45: TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 46: TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANTATION DIAGNOSTICS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 47: TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANTATION DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 48: TRANSPLANT DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 49: TRANSPLANT DIAGNOSTICS MARKET FOR HISTOCOMPATIBILITY TESTING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 50: TRANSPLANT DIAGNOSTICS MARKET FOR BLOOD PROFILING, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 51: TRANSPLANT DIAGNOSTICS MARKET FOR POST-TRANSPLANTATION DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 52: TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 53: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 54: TRANSPLANT DIAGNOSTICS MARKET FOR INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 55: TRANSPLANT DIAGNOSTICS MARKET FOR HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 56: TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 57: TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 58: TOTAL NUMBER OF SOLID ORGAN TRANSPLANTATIONS ACROSS KEY COUNTRIES (2016)
  • TABLE 59: NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 60: NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 61: NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 63: NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016-2023 (USD MILLION)
  • TABLE 64: NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 65: NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 67: US: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 68: US: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 69: US: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 70: CANADA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 71: CANADA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 72: CANADA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 73: EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 74: EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 75: EUROPE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: EUROPE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 77: EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016-2023 (USD MILLION)
  • TABLE 78: EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 79: EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: EUROPE: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 81: GERMANY: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 82: GERMANY: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: GERMANY: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 84: ORGAN TRANSPLANTATIONS PERFORMED IN THE UK, 2013 VS. 2015
  • TABLE 85: UK: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 86: UK: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 87: UK: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 88: FRANCE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 89: FRANCE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: FRANCE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 91: ROE: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 92: ROE: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: ROE: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 94: ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 95: ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 96: ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 97: ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016-2023 (USD MILLION)
  • TABLE 99: ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 100: ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 102: JAPAN: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 103: JAPAN: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 104: JAPAN: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 105: ORGAN TRANSPLANTATIONS PERFORMED IN CHINA, 2013 VS. 2015
  • TABLE 106: CHINA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 107: CHINA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 108: CHINA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 109: INDIA: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 110: INDIA: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: INDIA: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: SOLID-ORGAN TRANSPLANTATIONS PERFORMED IN THE ROAPAC, 2013 VS. 2016
  • TABLE 113: ROAPAC: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 114: ROAPAC: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 115: ROAPAC: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 116: ROW: TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 117: ROW: TRANSPLANT DIAGNOSTICS MARKET FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 118: ROW: TRANSPLANT DIAGNOSTICS MARKET FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 119: ROW: TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2016-2023 (USD MILLION)
  • TABLE 120: ROW: TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 121: ROW: TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: ROW: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARIES: GLOBAL TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 3: MARKET SIZE ESTIMATION: TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 4: DATA TRIANGULATION METHODOLOGY
  • FIGURE 5: REAGENTS AND CONSUMABLES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2023
  • FIGURE 6: SEQUENCE-SPECIFIC OLIGONUCLEOTIDES-PCR SEGMENT WILL CONTINUE TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET IN 2023
  • FIGURE 7: SOLID ORGAN TRANSPLANTATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2018
  • FIGURE 8: INFECTIOUS DISEASE TESTING SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2018
  • FIGURE 9: INDEPENDENT REFERENCE LABORATORIES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 11: GROWTH IN TRANSPLANTATION PROCEDURES TO DRIVE THE DEMAND FOR TRANSPLANT DIAGNOSTIC PRODUCTS TILL 2023
  • FIGURE 12: PCR-BASED MOLECULAR ASSAYS TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, DURING THE FORECAST PERIOD
  • FIGURE 13: INFECTIOUS DISEASE TESTING AND HISTOCOMPATIBILITY TESTING SEGMENTS TO WITNESS HIGH GROWTH IN THE ASIA PACIFIC MARKET
  • FIGURE 14: INDEPENDENT REFERENCE LABORATORIES WILL DOMINATE THE ASIA PACIFIC TRANSPLANT DIAGNOSTICS END-USER MARKET IN 2018
  • FIGURE 15: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST MARKET FOR ALL PRODUCTS & SERVICES SEGMENTS IN THE TRANSPLANT DIAGNOSTICS MARKET IN 2018
  • FIGURE 16: KIDNEY TRANSPLANTATION SEGMENT TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: CHINA AND INDIA IS ESTIMATED TO BE THE FASTEST-GROWING TRANSPLANT DIAGNOSTICS MARKET
  • FIGURE 18: TRANSPLANT DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: SOLID ORGAN TRANSPLANTATION PROCEDURES PERFORMED ACROSS MAJOR COUNTRIES, 2016
  • FIGURE 20: REAGENTS & CONSUMABLES TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 21: PCR-BASED MOLECULAR ASSAYS SEGMENT TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: KIDNEY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE TRANSPLANT DIAGNOSTICS MARKET IN 2018
  • FIGURE 23: INFECTIOUS DISEASE TESTING TO DOMINATE THE TRANSPLANT DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: INDEPENDENT REFERENCE LABORATORIES TO REGISTER THE HIGHEST CAGR IN THE TRANSPLANT DIAGNOSTICS MARKET DURING 2018-2023
  • FIGURE 25: NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT (2018-2023)
  • FIGURE 26: SOLID-ORGAN TRANSPLANTATIONS PERFORMED IN THE US, 2013-2017
  • FIGURE 27: TISSUE TRANSPLANTATIONS PERFORMED IN THE US, 2013-2017
  • FIGURE 28: SOLID-ORGAN TRANSPLANTATIONS PERFORMED IN CANADA, 2015 VS. 2016
  • FIGURE 29: EUROPE: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT (2018-2023)
  • FIGURE 30: ASIA PACIFIC: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT (2018-2023)
  • FIGURE 31: SOLID-ORGAN TRANSPLANTATIONS PERFORMED IN JAPAN, 2013 TO 2017
  • FIGURE 32: ROW: TRANSPLANT DIAGNOSTICS MARKET SNAPSHOT (2018-2023)
  • FIGURE 33: PRODUCT LAUNCHES AND ENHANCEMENTS, KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2014 TO 2018
  • FIGURE 34: BIO-RAD LABORATORIES HELD THE LEADING POSITION IN THE GLOBAL TRANSPLANT DIAGNOSTICS MARKET AS OF 2017
  • FIGURE 35: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS (2017)
  • FIGURE 36: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
  • FIGURE 37: BIOMERIEUX: COMPANY SNAPSHOT (2017)
  • FIGURE 38: BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017)
  • FIGURE 39: CAREDX: COMPANY SNAPSHOT (2017)
  • FIGURE 40: F. HOFFMAN-LA ROCHE LIMITED: COMPANY SNAPSHOT (2017)
  • FIGURE 41: HOLOGIC: COMPANY SNAPSHOT (2017)
  • FIGURE 42: ILLUMINA: COMPANY SNAPSHOT (2017)
  • FIGURE 43: IMMUCOR: COMPANY SNAPSHOT (2016)
  • FIGURE 44: LUMINEX: COMPANY SNAPSHOT (2017)
  • FIGURE 45: MERCK KGAA: COMPANY SNAPSHOT (2017)
  • FIGURE 46: QIAGEN: COMPANY SNAPSHOT (2017)
  • FIGURE 47: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research